Over the past two years, under the leadership of Ewan and David,...

Over the past two years, under the leadership of Ewan and David, we have seen progress that surpasses that of previous directors. IMO

Regarding Anteobind, our engagement with one of the largest vaccine manufacturers is ongoing. This process will be gradual, and while an immediate deal is unlikely, we will hopefully signa deal within the next six months it is a nurturing process.

Previously, our efforts with Mix and No yielded no significant results, but the current trajectory shows promise.

For Anteo X, David’s leadership has positioned us to launch commercially, especially with the new Pilot plant serving as a global launchpad.

Comparing our progress over the last 20 years to the advancements made in the past two years, the recent developments are remarkable especially coming from a court case four IP only 3 months ago ( you can basically say they have really only been at the helm around a year and a bit ).

Changing management at this crucial juncture would be detrimental.

Dealing with major companies involves a lengthy approval process, and decision-makers will ensure the product is thoroughly tested and meets all requirements before committing.

Cheers

M.oz